AUTHOR=Betenbuk Judit , Vereczkey Ildikó , Szalai Luca , Simon Andrea , Tóth Erika , Kuthi Levente , Melegh Zsombor TITLE=Molecular characterisation of mixed and dedifferentiated endometrial carcinomas reveals shared pathogenesis and clonal origin JOURNAL=Pathology and Oncology Research VOLUME=Volume 32 - 2026 YEAR=2026 URL=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2026.1612616 DOI=10.3389/pore.2026.1612616 ISSN=1532-2807 ABSTRACT=ObjectivesMixed carcinoma of the endometrium (MCE) is an epithelial malignancy composed of two or more histological types. The recent WHO classification of MCE differs from its ovarian counterpart: dedifferentiated carcinomas are excluded from MCE, whereas ovarian dedifferentiated carcinomas are considered a special type of mixed carcinoma. However, the genetic basis of MCE remains poorly understood, as studies with comprehensive genomic analyses are scarce. This study aimed to identify genetic alterations involved in the development of MCE and endometrial dedifferentiated carcinomas (EDC) using next-generation sequencing (NGS) data and to determine whether MCE and EDC show distinct pathogenetic features supporting their classification as separate entities.MethodsWe retrospectively reviewed 1,578 endometrial carcinomas treated at or referred to our institute between January 2017 and December 2025. Mixed carcinomas were identified by morphological examination and immunohistochemistry. NGS using the Oncomine Comprehensive Assay V3 was performed separately on each component of six MCEs. Although EDCs are not classified as mixed carcinomas according to WHO criteria, nine such cases were also analysed for comparison.ResultsExcluding carcinosarcomas, MCEs accounted for 0.63% (10/1,578) of endometrial carcinomas, while EDCs represented 0.57% (9/1,578). With one exception, all MCEs and EDCs shared at least one identical pathogenic mutation between their components, supporting a clonal relationship. Among MCEs, 60% (6/10) showed mismatch repair deficiency (dMMR) in at least one component, and one case harboured a POLE mutation. Similarly, 89% (8/9) of EDCs were dMMR in at least one component, while one case was POLE-mutated. Both tumour groups frequently harboured alterations in the SWI/SNF and PI3K/AKT pathways, particularly involving ARID1A, PIK3CA, and PTEN. ARID1A mutations were especially frequent in EDCs (7/9, 78%).ConclusionThe components of almost all MCE and EDC were clonally related, suggesting development through transdifferentiation or divergent differentiation rather than independent collision. Despite their classification as separate entities in the current WHO system, both tumour types appear to arise predominantly in the setting of dMMR and genomic hypermutability. These findings provide further insight into the molecular pathogenesis of mixed carcinomas of the female genital tract and may contribute to future refinements in their classification.